NDC 54766-093

RIDAURA

Auranofin

RIDAURA is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sebela Pharmaceuticals Inc.. The primary component is Auranofin.

• Product ID: 54766-093_7cfc87e7-a349-eed3-e053-2991aa0afd6a
• NDC: 54766-093
• Product Type: Human Prescription Drug
• Proprietary Name: RIDAURA
• Generic Name: Auranofin
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2016-12-15
• Marketing Category: NDA / NDA
• Application Number: NDA018689
• Labeler Name: Sebela Pharmaceuticals Inc.
• Substance Name: AURANOFIN
• Active Ingredient Strength: 3 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 54766-093-06

60 CAPSULE in 1 BOTTLE (54766-093-06)

• Marketing Start Date: 2016-12-15
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 54766-093-06 [54766009306]

RIDAURA CAPSULE

• Marketing Category: NDA
• Application Number: NDA018689
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2016-12-15

Drug Details

Active Ingredients

Ingredient	Strength
AURANOFIN	3 mg/1

OpenFDA Data

• SPL SET ID: 43ba3de1-ab2e-06f6-e054-00144ff8d46c
• Manufacturer:
  • Sebela Pharmaceuticals Inc.
• UNII:
  • 3H04W2810V
• RxNorm Concept Unique ID - RxCUI:
  • 197386
  • 213510
• UPC Code:
  • 0354766093067

NDC Crossover Matching brand name "RIDAURA" or generic name "Auranofin"

NDC	Brand Name	Generic Name
54766-093	RIDAURA	auranofin
65483-093	RIDAURA	auranofin